Analysis of Immunomodulatory Effects and Clinical Efficacy of Romiplostim in the Treatment of Primary Immune Thrombocytopenia

Advances in Clinical Medicine 2026

View at publisher

Authors: 裴昕张

DOI: 10.12677/acm.2026.161166

Cited by: 0

References: 18

Fields of Study & Subjects

Platelet Disorders and Treatments Heparin-Induced Thrombocytopenia and Thrombosis Blood groups and transfusion

References 18